Back to search

Article

Study protocol: Sonidegib for Nevoid Basal Cell Carcinoma (Gorlin) Syndrome and EADO stage IIb Sporadic BCC, a phase II Study (SIBLINGS TRIAL).EU CT n. 2024-515989-14-00

2026-03-25

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Nevoid Basal Cell Carcinoma Syndrome (NBCCS), or Gorlin syndrome, is a rare genetic condition characterized by multiple basal cell carcinomas (BCCs) and increased risk of other malignancies. In this population, surgery and radiotherapy are often unfeasible, making systemic treatment a necessity. Similarly, some sporadic BCC patients present extensive lesions,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8f03616-f1c4-5b74-8899-af3c31b85268
DOI
10.21203/rs.3.rs-7761392/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Study protocol: Sonidegib for Nevoid Basal Cell Carcinoma (Gorlin) Syndrome and EADO stage IIb Sporadic BCC, a phase II Study (SIBLINGS TRIAL).EU CT n. 2024-515989-14-00DOI 10.21203/rs.3.rs-7761392/v1
Clues to primary vismodegib resistance lie in histology and geneticsSemantic proximity
Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trialsSemantic proximity
Long-term Response to Vismodegib in a Patient with Gorlin-Goltz Syndrome: A Case Report and Review of Pathological Mechanisms InvolvedSemantic proximity
Acquisition of drug resistance in basal cell nevus syndrome tumors through basal to squamous cell carcinoma transitionSemantic proximity
An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.Semantic proximity
Resistance to SMO Inhibitors in Advanced Basal Cell Carcinoma: A Case Highlighting the Role of Molecular Tumor Profiling.Semantic proximity
Diagnosis and Management of Hereditary Basal Cell Skin Cancer.Semantic proximity
Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.Semantic proximity
Targeting the hedgehog pathway to treat basal cell carcinoma.Semantic proximity
A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the LiteratureSemantic proximity
Hypothesis of Leopold Gecko Chromatophoromas Diagnose &amp; Treatment Model Based on Clinical Diagnosis and Treatment in 2023-2024Semantic proximity
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.Semantic proximity
Select a neighboring publication to make it the new centre.